In Q2 FY23, ACC Limited (NSE: ACC) reported Revenue growth of 7% year over year to ₹3,910.49 Crore from ₹3,653.3 Crore. The company posted a Consolidated Net Loss of ₹87.32 Crore and ₹-4.65 as Earnings per Share.
![](data:image/svg+xml;charset=utf-8,<svg height="727px" width="640px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
ACC Limited Q2FY23; Consolidated Net Loss of 87.32 Crore
Related Post
- Aurobindo Pharma Ltd Q4FY25; 0% fall in Profits
Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals…
-
Astral Ltd Q4FY25; 2% fall in Profits
Astral Poly Technik Ltd was established in 1996, with the aim to manufacture pro-India plumbing…
-
Astrazeneca Pharma India Ltd Q4FY25; 3% rise in Revenue
AstraZeneca Pharma India Ltd is engaged in the business of manufacture, distribution and marketing of…